Design, Synthesis, and Evaluation of Novel Phenoselenazine Derivatives as Potent Modulators of Aβ42 Aggregation
Journal of Medicinal Chemistry · 13.08.2026 · 69 (15) · 19482-19501
DOI: 10.1021/acs.jmedchem.6c01959 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 27.07.2026. Verfasst von Ahmed A Hefny und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Health Sciences Campus, University of Waterloo, 200 University Avenue West, Waterloo, OntarioN2L 3G1, Canada. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Drug Design, Organoselenium Compounds, Antioxidants. Die Arbeit nennt 77 Literaturangaben. Gefördert von: Ontario Research Foundation, Egyptian Cultural and Educational Bureau, Abu Dhabi University.
Abstract (Originalsprache)
A novel class of fused tricyclic phenoselenazine derivatives possessing a redox-active selenium atom were designed, synthesized, and evaluated as Aβ42 aggregation inhibitors with antioxidant activity. They exhibit remarkable inhibition of Aβ42 aggregation as confirmed by fluorescence aggregation kinetics study, electron microscopy, and cell-based studies in mouse hippocampal HT22 neuronal and BV2 microglial cells. Compounds 5i and 9g exhibited potent inhibition of Aβ42 aggregation with IC50 values of 350 and 317 nM, respectively, with compound 9g exhibiting exceptional ability to destabilize preformed Aβ42 fibrils (IC50 = 210 nM), surpassing those of the reference compounds resveratrol and methylene blue. Both 5i and 9g showed efficient blood–brain barrier permeability and provided significant neuroprotection toward Aβ42-induced cytotoxicity and demonstrated strong antioxidant properties by conferring protection toward hydrogen peroxide-induced cytotoxicity in mouse hippocampal HT22 cells. Collectively, our results demonstrate that these novel phenoselenazines represent a promising class of therapeutics to treat Alzheimer’s disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Health Sciences Campus, University of Waterloo, 200 University Avenue West, Waterloo, OntarioN2L 3G1, Canada.
- Medicinal Chemistry Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef62514, Egypt.
- Chemical Engineering Department, Abu Dhabi University, Abu Dhabi, United Arab Emirates.
ORCID-Profile: Chandra Mouli R Madhuranthakam, Praveen P N Rao
Förderung
- Ontario Research Foundation
- Egyptian Cultural and Educational Bureau
- Abu Dhabi University
- Natural Sciences and Engineering Research Council of Canada
- Canada Foundation for Innovation
- Ministry of Higher Education and Scientific Research
- Ontario Ministry of Research and Innovation
- Ministry of Colleges and Universities
Zitieren
APA
Hefny, A. A., Karuturi, R. C., Madhuranthakam, C. M. R., & Rao, P. P. N. (2026). Design, Synthesis, and Evaluation of Novel Phenoselenazine Derivatives as Potent Modulators of Aβ42 Aggregation. Journal of Medicinal Chemistry, 69(15), 19482-19501. https://doi.org/10.1021/acs.jmedchem.6c01959
Vancouver
Hefny AA, Karuturi RC, Madhuranthakam CMR, Rao PPN. Design, Synthesis, and Evaluation of Novel Phenoselenazine Derivatives as Potent Modulators of Aβ42 Aggregation. Journal of Medicinal Chemistry. 2026;69(15):19482-19501. doi:10.1021/acs.jmedchem.6c01959
BibTeX
@article{Hefny2026,
author = {Hefny, Ahmed A and Karuturi, Rahul C and Madhuranthakam, Chandra Mouli R and Rao, Praveen P N},
title = {Design, Synthesis, and Evaluation of Novel Phenoselenazine Derivatives as Potent Modulators of Aβ42 Aggregation},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {15},
pages = {19482--19501},
doi = {10.1021/acs.jmedchem.6c01959}
}
EUVIMED